InsiderClue
Insiders · Profile

Bhanji Muna

Director at VERACYTE · Director at CYTOKINETICS · Director at Intellia Therapeutics. Filing since 30 May 2023. CIK 0001846905

VCYT VERACYTE, INC. Director · 6 trades CYTK CYTOKINETICS INC Director · 3 trades NTLA Intellia Therapeutics, Inc. Director · 5 trades
Company
Date
Role
Action
Shares
Amount
Of holding
VCYT VERACYTE, INC.
1 Sep 2026
Director
Sold on a plan
1,864
$80.10K
4.2%
VCYT VERACYTE, INC.
13 Jun 2025
Director
Sold on a plan
4,589
$122.37K
13.3%
CYTK CYTOKINETICS INC
15 May 2025
Director
Sold on a plan
1,454
$43.23K
5.8%
NTLA Intellia Therapeutics, Inc.
29 Apr 2025
Director
Sold on a plan
265
$2.25K
1.4%
NTLA Intellia Therapeutics, Inc.
29 Jan 2025
Director
Sold on a plan
265
$2.64K
1.3%
CYTK CYTOKINETICS INC
10 Jun 2024
Director
Sold on a plan
2,000
$104.14K
10.2%
VCYT VERACYTE, INC.
10 Jun 2024
Director
Sold on a plan
3,870
$78.63K
14.3%
VCYT VERACYTE, INC.
28 May 2024
Director
Sold on a plan
1,539
$32.32K
5.4%
NTLA Intellia Therapeutics, Inc.
31 Oct 2023
Director
Sold on a plan
265
$6.33K
2.2%
NTLA Intellia Therapeutics, Inc.
31 Jul 2023
Director
Sold on a plan
265
$11.22K
2.1%
CYTK CYTOKINETICS INC
7 Jul 2023
Director
Sold on a plan
2,000
$68.23K
12.5%
NTLA Intellia Therapeutics, Inc.
6 Jul 2023
Director
Sold on a plan
1,867
$73.37K
13.0%
VCYT VERACYTE, INC.
16 Jun 2023
Director
Sold on a plan
5,893
$155.79K
17.1%
VCYT VERACYTE, INC.
30 May 2023
Director
Sold at will
1,539
$39.88K
5.9%
14 decisions on file.